Journal of Clinical Investigation · 1998 · 238 citations · 44 references
Life SciencesImmunologyMolecular BiologyCancer ImmunologyImmunotherapyMolecular ImmunologyB Cell BiologyB-cell ResponsesCancer ImmunotherapyCell-mediated ImmunityCytotoxic T Lymphocyte ResponsesHumoral ImmunityAdenovirus VectorsAntigen Presenting CellsAntitumor Immune ActivationB Cell-mediated ImmunityB-cell Mediated ImmunityImmune Cell ActivationImmune Effector MoleculesMixed Lymphocyte Reaction
CD40-CD40-ligand (CD154) interactions play a critical role in immune activation. Using replication defective adenovirus encoding mouse CD154 (Ad-CD154), we modified human chronic lymphocytic leukemia B cells to express a functional ligand for CD40. This not only induces expression of immune accessory molecules on the infected cell, but also allows it to trans-activate noninfected bystander leukemia B cells. Also, factors that impair the antigen-presenting capacity of leukemia B cells are downmodulated. Ad-CD154- infected leukemia cells are highly effective stimulators in mixed lymphocyte reactions and can induce generation of cytotoxic T lymphocytes specific for autologous nonmodified leukemia cells. As such, Ad-CD154 can induce a host antileukemia response that may have therapeutic potential.
44
I. Vermes, C. Haanen, H M Steffens-Nakken et al. · Journal of Immunological Methods · 1995 · 5.4K citations · Full text
Glen Dranoff, Elizabeth M. Jaffee, A Lazenby et al. · Proceedings of the National Academy of Sciences · 1993 · 2.8K citations
Medicine, Immunology, Oncology +17
Gerrit Koopman, CP Reutelingsperger, GA Kuijten et al. · Blood · 1994 · 2.5K citations · Full text
Medicine, Cell Biology, Pathology +11
Gerrit Koopman, CP Reutelingsperger, GA Kuijten et al. · Blood · 1994 · 2.1K citations
Medicine, Cell Biology, Pathology +11
A Cell Culture Model for T Lymphocyte Clonal Anergy
Ronald H. Schwartz · Science · 1990 · 1.9K citations